| Literature DB >> 17194588 |
Richard M Angell1, Francis L Atkinson, Murray J Brown, Tsu Tshen Chuang, John A Christopher, Maria Cichy-Knight, Allison K Dunn, Kendra E Hightower, Susanna Malkakorpi, James R Musgrave, Margarete Neu, Paul Rowland, Robyn L Shea, Jeffery L Smith, Donald O Somers, Sonia A Thomas, Gladstone Thompson, Ruolan Wang.
Abstract
The identification and exploration of a novel, potent and selective series of N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amide inhibitors of JNK2 and JNK3 kinases is described. Compounds 5a and 11a were identified as potent inhibitors of JNK3 (pIC50 6.7 and 6.6, respectively), with essentially equal potency against JNK2 (pIC50 6.5). Selectivity within the mitogen-activated protein kinase (MAPK) family, against JNK1, p38alpha and ERK2, was observed for the series. X-ray crystallography of 5e and 8a in JNK3 revealed a unique binding mode, with the 3-cyano substituent forming an H-bond acceptor interaction with the hinge region of the ATP-binding site.Entities:
Mesh：
Substances：
Year: 2006 PMID： 17194588 DOI： 10.1016/j.bmcl.2006.12.003
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN： 0960-894X Impact factor: 2.823